The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released

Zhou Xingting

Yao jian

"Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park.

  The world's first effective Chinese patent medicine for COVID-19 treatment

  Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia

   On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, china-Belarus Industrial Park Development Company and National Brand Engineering Office of Xinhua News Agency was held in Shanghai.

  Belarus first deputy prime minister mikhail khodorkovsky, of sinop Ren Hongbin deputy director of the State-owned Assets Supervision and Administration Commission of the State Council, deputy director of the macau ZhongLianBan yao jian, vice mayor of Qingdao Luan new, Xinhua News Agency, party members and the secretary-general GongXiXiang, Chinese ambassador to belarus Xie Xiaoyong, belarus ambassador sast, belarus, vice minister of the economy, fund, deputy health minister adela, Zhou Xingting, Chairman of Nanyue Group, CAI Chuanqing, president of Jintai Cultural Institute and Chairman of New Era Biotechnology Co., LTD attended the meeting and delivered speeches.

  At the event, the world's first effective Chinese patent medicine for COVID-19 treatment, "Linglan Phytophthora" (also known as "Phytophthora Capsule") was officially released. At the signing ceremony, we will register and apply, manufacture locally and sell globally, jointly build a service platform for the whole international TCM industry chain, and strive to promote the standardization, technology and internationalization of TCM industry.

  Strengthen immunity and restore function

  "Linglan Qingqing" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park. It is the world's first special proprietary Chinese medicine for COVID-19 treatment. According to introducing, "ling qing LAN epidemic" series of preparations from September 18th a. a. years ago classic party in treatise on febrile disease, combined with the disease article distinguishes between "traditional Chinese medicine such as the successful experience of the fight against infectious diseases, combined with modern medicine, for will be coronavirus spread fast, the disease progresses, the characteristics of high fatality rate and sequelae, a new formula. Novel Coronavirus can effectively inhibit novel Coronavirus, reduce the damage of novel Coronavirus to human organs and immune system, and then achieve the effect of treating COVID-19 by improving immunity and restoring body function.

  "In a very short period of time, the Ministry of Health of Belarus has registered the clearance capsule as an important strategic drug in Belarus for the prevention and treatment of novel Coronavirus." Nikolai Snopkov, first Deputy Prime Minister of Belarus, said in his speech that "we see the future of the pharmaceutical industry in the combined wisdom of TRADITIONAL Chinese medicine and technological innovation".

  According to the cooperation agreement, "Linglan Zhuoqing" to be introduced by Nanyue Group is expected to become the first approved Chinese patent medicine for the treatment of COVID-19 after the implementation of The Registration Law of Traditional Chinese Medicine activities and Chinese Patent Medicine in Macao, so as to realize the production in Macao and export to the global market by taking full advantage of the "double circulation" hub advantage of Macao.

  Invite big health enterprises to Australi

  Yao jian fully recognized in the speech nan yue group for way cooperation to promote the high quality of traditional Chinese medicine industry development as well as the important force in the contribution of "going out" of Chinese medicine, believe nan yue group company and the new era of biological science and technology cooperation signed for future strategic cooperation, the two sides to carry out the international TCM industry to promote the two sides of Chinese medicine industry resources interactive to each other, The realization of industrial policy complementarity and mutual enjoyment will play an important role in promoting. He said that the Liaison Office of the Central Committee of the Communist Party of China (CPC) Macao will continue to give full support to Macao's moderately diversified economic development, support the two sides in strengthening exchanges and cooperation, and push for greater progress in Macao's participation in the Belt and Road Initiative.

  At the event, Zhou strongly introduced Macao's comprehensive advantages in developing TRADITIONAL Chinese medicine and sincerely invited advanced Chinese medicine enterprises and high-quality products from all over the world to settle in Macao. He said that Nanyue Group always keeps in mind the original mission of supporting the moderately diversified development of Macao's economy, and gives full play to the resource advantages of Guangdong and Macao cooperation. Nanyue Science and Technology Park, a Chinese medicine and health industrial park with the most complete industrial development foundation and the greatest development potential, has been built in Macao. It has built a service platform for the whole industry chain of TCM great health, covering global direct procurement of raw materials, global patent cooperation, Macao registration and declaration, Macao manufacturing inspection, and global diversified sales, which is accelerating to become an important engine to promote the development of TCM industry in Macao. Nanyang Group will continue to provide customized services for the global industry customers in the registration and application of new drugs, r&d, conversion and manufacturing, as well as global diversified sales in Macao. Nanyang Group will share resources and complement advantages with various scientific research institutions and TRADITIONAL Chinese medicine enterprises, and make full use of modern science and technology to promote the inheritance, innovation and international development of traditional Chinese medicine.